Simrat Randhawa, Chief Medical Officer at Dianthus Therapeutics, Inc. /DE/ (DNTH), bought 4,000 shares at $13.20 ($53K) on 2023-09-21, disclosed to the SEC on 2023-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.20 | 2,000 | $26K | 50.0% |
| 2 | $13.20 | 2,000 | $26K | 50.0% |
| Total | $13.20 avg | 4,000 | $53K | 100% |
| Filing → |
| DNTH | SELL | 2026-03-13 | $2.8M | — | Filing → |
| DNTH | SELL | 2025-11-14 | $14.8M | — | Filing → |